In this episode of the “CURE Talks Cancer” podcast we interview genetic counselor Dana Farengo Clark on how genetic counseling is adjusting to the new normal and shifting into the virtual era of cancer care.
While it’s true that telemedicine has become widely used as a result of the COVID-19 pandemic, all signs are pointing to it being a part of the new normal as we look to the future of cancer care.
Genetic counselors are now being trained to meet with patients virtually to ensure those with a genetic predisposition to cancer are still being taken care of despite the lack of face-to-face visits.
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dana Farengo Clark, a genetic counselor at UPenn’s Basser Center for BRCA, to discuss the work being done at the center for genetic counseling, and how telemedicine is just as important now, more than ever, in identifying an individual’s risk for cancer to explore their options once they have that information.
